Society needs to “take seriously the rewards for innovators” through the patent system to improve the biotech investing climate, New Enterprise Associates Inc. General Partner James Barrett said Thursday.
Speaking before a crowd at the Mid-Atlantic BIO conference, held in Bethesda this week by the MdBio division of the Tech Council of Maryland, VaBio and the Mid-Atlantic Venture Association, Barrett voiced a defense of stronger intellectual property protections for bio entrepreneurs.
{iframe}http://www.bizjournals.com/washington/blog/2012/09/neas-jim-barrett-drug-innovation.html?ana=e_wash_rdup&s=newsletter&ed=2012-09-28{/iframe}